Cargando…
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
Autores principales: | Thachil, Jecko, Tang, Ning, Gando, Satoshi, Falanga, Anna, Cattaneo, Marco, Levi, Marcel, Clark, Cary, Iba, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906133/ https://www.ncbi.nlm.nih.gov/pubmed/32338827 http://dx.doi.org/10.1111/jth.14810 |
Ejemplares similares
-
RE: ISTH interim guidance to recognition and management of coagulopathy in COVID‐19
por: Akima, Satoshi, et al.
Publicado: (2020) -
Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020) -
DOACs and “newer” hemophilia therapies in COVID‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020) -
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A comment
por: Barrett, Christopher D., et al.
Publicado: (2020) -
Curated disease‐causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH
por: Megy, Karyn, et al.
Publicado: (2019)